ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

Gleevec Decreases Recurrence Of Gastrointestinal Tumor

April 27, 2007

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010